Chemotherapy News and Research

Latest Chemotherapy News and Research

Study opens a promising new front in the fight against pancreatic cancer

Pancreatic adenocarcinoma (PDAC) is a lethal malignancy that most often is resistant to chemotherapy. Researchers have been searching for ways to increase the sensitivity of the tumors to cancer-fighting drugs.

19 Sep 2019

NUS chemists develop new anti-cancer drug with less renal toxicity

A team of pharmacists and chemists from the National University of Singapore has developed a new anti-cancer drug that has less toxic effects to the kidneys.

18 Sep 2019

Compound could play a novel role in halting spread of pancreatic cancer

In early test tube and mouse studies, investigators at Johns Hopkins Medicine and the Johns Hopkins Kimmel Cancer Center have found that nonmuscle myosin IIC (MYH14), a protein activated in response to mechanical stress, helps promote metastatic behavior in pancreatic cancer cells, and that the compound 4-hydroxyacetophenone (4-HAP), known to stiffen myosin IIC-containing cells, can send it into overdrive, overwhelming the ability of cells to invade nearby tissue.

18 Sep 2019

Study examines racial disparities in survival outcomes of pediatric patients with Hodgkin lymphoma

In what is believed to be the largest dataset study to date examining the role of race on survival outcome for pediatric patients with Hodgkin lymphoma, investigators at Rutgers Cancer Institute of New Jersey have found that black patients have significantly worse overall survival at five years than white patients when accounting for all available clinical variables.

18 Sep 2019

Cancer cells survive chemotherapy by eating their neighboring tumor cells

Researchers from the Tulane University School of Medicine have discovered that some cancer cells survive chemotherapy by eating their neighboring tumor cells.

17 Sep 2019

Researchers develop new anti-cancer nanomedicine for targeted chemotherapy

Researchers at the University of Helsinki in collaboration with researchers from Åbo Akademi University, Finland and Huazhong University of Science and Technology, China have developed a new anti-cancer nanomedicine for targeted cancer chemotherapy.

17 Sep 2019

Scientists pinpoint cause of fatal genetic disorder in children

Scientists at Washington University School of Medicine in St. Louis appear to have solved a decades-long mystery regarding the precise biochemical pathway leading to a fatal genetic disorder in children that results in seizures, developmental regression and death, usually around age 3.

17 Sep 2019

New biomarkers help predict response to treatment in common brain tumor

Many scientists have noted that there is a link between inflammation or the immune response, and patient survival. One such possible relationship is the association of blood markers and the prognosis in the brain tumor called medulloblastoma.

16 Sep 2019

Study finds rise in off-label medication orders for children

U.S. physicians are increasingly ordering medications for children for conditions that are not approved by the Food and Drug Administration, according to a Rutgers study.

16 Sep 2019

Nano-sized bubbles in our body could effectively fight cancer

Healthy cells in our body release nano-sized bubbles that transfer genetic material such as DNA and RNA to other cells. It's your DNA that stores the important information necessary for RNA to produce proteins and make sure they act accordingly.

15 Sep 2019

Metastatic colorectal cancer patients with certain BRAF mutations may respond to anti-EGFR therapy

Patients with metastatic colorectal cancer harboring a subset of non-V600 mutations in the BRAF gene, known as class 3 BRAF mutations, were more likely to respond to anti-EGFR treatment.

12 Sep 2019

Deadly infections on the rise: New classes of antibiotics are desperately needed

Globally, the number of deaths from infections is on the rise as more bacteria become resistant to antibiotics.

12 Sep 2019

Georgia Cancer Center awarded $6 million grant to improve access to clinical trials

The Georgia Cancer Center at Augusta University has been awarded a six-year $6 million grant from the National Cancer Institute to lead a statewide initiative that improves access to innovative clinical trials for a variety of cancers to underserved individuals across Georgia.

12 Sep 2019

Gene coding error likely responsible for rare form of inherited 'short telomere' disease

By combing through the entire genetic sequences of a person with a lung scarring disease and 13 of the person’s relatives, Johns Hopkins Medicine researchers say they have found a coding error in a single gene that is likely responsible for a rare form of the disease and the abnormally short protective DNA caps on chromosomes long associated with it.

From Johns Hopkins Medicine 11 Sep 2019

HORIBA’s Yumizen hematology analyzers minimize microscopy slide reviews, improve diagnosis

HORIBA UK Ltd, Medical announces the publication of scientific studies which demonstrate the excellent performance of its new HELO high throughput fully automated haematology platform on body fluid and pathological samples.

From HORIBA Scientific UK 11 Sep 2019

Study seeks to better understand, treat neuropathy in black women with breast cancer

Researchers at Indiana University School of Medicine have launched a new, unique study recruiting black women with breast cancer designed to better understand and treat neuropathy, a side effect from chemotherapy.

10 Sep 2019

Bias against unmarried cancer patients affects their treatment

Unmarried patients with cancer are less likely to get potentially life-saving surgery or radiotherapy than their married counterparts, raising the concern that medical providers may be relying on stereotypes that discount sources of social support other than a current spouse.

10 Sep 2019

Mutations linked with sensitivity or resistance to immunotherapy in mNSCLC

The relationship between gene alterations and response to anti-PD-L1 with and without anti-CTLA-4 are not well characterized.

10 Sep 2019

Researchers discover potential of antihistamines that cause death of leukemic stem cells

Ruth M. Risueño leads the Leukaemic Stem Cell group of the Josep Carreras Leukaemia Research Institute. This group investigates Acute Myeloid Leukemia and the cell population responsible for the disease spreading, persisting, and if it has been treated and overcome, reappear.

6 Sep 2019

New drug may enhance efficacy of chemotherapy in pancreatic cancer

One of the major obstacles in the treatment of pancreatic cancer is the 'defense wall' that is formed around the tumor.

5 Sep 2019

Chemotherapy News and Research

Latest Chemotherapy News and Research

Study opens a promising new front in the fight against pancreatic cancer

NUS chemists develop new anti-cancer drug with less renal toxicity

Compound could play a novel role in halting spread of pancreatic cancer

Study examines racial disparities in survival outcomes of pediatric patients with Hodgkin lymphoma

Cancer cells survive chemotherapy by eating their neighboring tumor cells

Researchers develop new anti-cancer nanomedicine for targeted chemotherapy

Scientists pinpoint cause of fatal genetic disorder in children

New biomarkers help predict response to treatment in common brain tumor

Study finds rise in off-label medication orders for children

Nano-sized bubbles in our body could effectively fight cancer

Metastatic colorectal cancer patients with certain BRAF mutations may respond to anti-EGFR therapy

Deadly infections on the rise: New classes of antibiotics are desperately needed

Georgia Cancer Center awarded $6 million grant to improve access to clinical trials

Gene coding error likely responsible for rare form of inherited 'short telomere' disease

HORIBA’s Yumizen hematology analyzers minimize microscopy slide reviews, improve diagnosis

Study seeks to better understand, treat neuropathy in black women with breast cancer

Bias against unmarried cancer patients affects their treatment

Mutations linked with sensitivity or resistance to immunotherapy in mNSCLC

Researchers discover potential of antihistamines that cause death of leukemic stem cells

New drug may enhance efficacy of chemotherapy in pancreatic cancer

Cancer Research - Second Edition eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Newsletters you may be interested in